Skip to main content
. 2021 Sep 20;23(9):e29210. doi: 10.2196/29210

Table 1.

Participant demographic and clinical characteristics by study group at baseline (N=43).

Participant characteristics Virtual reality (n=15) Active control (n=14) Passive control (n=14) Total (n=43)
Age (years), mean (SD; range) 81.7 (6.6; 72-93) 85.9 (8.1; 71-95) 87 (8.7; 73-103) 84.8 (8.0; 71-103)
Sex (female), n (%) 10 (67) 9 (64) 9 (64) 28 (65)
Years of education, mean (SD) 11.7 (3.1) 10.7 (2.6) 11.0 (4.6) 11.2 (3.4)
Marital status, n (%)

Married 3 (20) 2 (14) 5 (36) 10 (23)

Divorced or widowed 11 (73) 11 (79) 8 (57) 30 (70)

Single 1 (7) 1 (7) 1 (7) 3 (7)
Depression and anxiety medication, n (%) 5 (33) 3 (21) 8 (57) 16 (37)
Primary diagnosis, n (%)

Memory-related, dementia, or Parkinson disease 5 (33) 3 (21) 3 (21) 11 (26)

Heart disease 8 (53) 4 (29) 8 (57) 20 (47)

Stroke 2 (13) 2 (14) 2 (14) 6 (14)

Other 0 (0) 5 (36) 1 (7) 6 (14)
Outcome measures at baseline, mean (SD)

Apathy Evaluation Scale 35.3 (8.7) 41.8 (7.1) 44.3 (9.5) 40.3 (9.1)

Geriatric Depression Scale 4.1 (3.6) 3.5 (2.5) 4.4 (3.0) 4.0 (3.0)

ACE-IIIa 72.9 (17.7) 71.2 (13.7) 72.2 (13.6) 72.1 (14.9)

QOL-ADb 35.4 (5.8) 36.1 (5.2) 32.9 (6.0) 34.8 (5.7)

Three-Item Loneliness Scale 4.5 (1.5) 4.2 (1.4) 5.0 (2.5) 4.6 (1.9)

aACE-III: Addenbrooke Cognitive Examination III.

bQOL-AD: Quality of Life in Alzheimer Disease.